Ivana Tabalipa Giublin et al. Camila Hartmann Otavio Celeste Mangili Afonso Akio Shiozaki Lídia Ana Zytynski Moura
Introduction
Cases of myocarditis and pericarditis have been reported in diverse parts of the world since vaccination against the new coronavirus began with messenger RNA (mRNA) vaccines, mainly those produced by Pfizer-BioNTech. The pathophysiology of this vaccine-induced pathology is not yet fully understood, but it may be related to the active component of the vaccine (the mRNA sequence that encodes the SARS-CoV-2 spike protein) or to the immune system response that is triggered after vaccination . What is known so far is that it is a rare adverse event in view of the number of people who have already been immunized with these components, and the vast majority of cases reported in the literature have a benign course, with good evolution. – We report a case of myopericarditis in a young adult who presented symptoms 2 days after receiving the second dose of the Pfizer vaccine against COVID-19.
[…]